Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Micellar Formulation of Silymarin with Enhanced Bioavailability in a Double-Blind, Randomized, Crossover Human Trial

NCT06882681 is registered in ClinicalTrials.gov with Isura as lead sponsor.

NCT NCT06882681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06882681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Micellar Formulation of Silymarin with Enhanced Bioavailability in a Double-Blind, Randomized, Crossover Human Trial
Lead sponsor
Isura
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2024
Completion date
January 31, 2025
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioavailability and pharmacokinetics